Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Konstantin Levitsky
Institution:
Amgen (United States)
Observed institution:
Amgen (United States)
OpenAlex ID:
A5078109136
Carfilzomib can induce tumor cell death through selective inhibition of the chymotrypsin-like activity of the proteasome
2009
·
Francesco Parlati
, Susan J. Lee
, et al.
·
Blood
·
324
Clinical activity of carfilzomib correlates with inhibition of multiple proteasome subunits: application of a novel pharmacodynamic assay
2016
·
Susan J. Lee
, Konstantin Levitsky
, et al.
·
British Journal of Haematology
·
33
PDF
Show more works
View as search
Works count:
2
Citation count:
357
H-index:
2
I10-index:
2
Year
Topic
Type
